Skip to main content
PMC home page
Emergency Medicine Journal : EMJ logoLink to Emergency Medicine Journal : EMJ
. 2005 Nov;22(11):766–771. doi: 10.1136/emj.2003.011965

When should we thrombolyse patients with pulmonary embolism? A systematic review of the literature

T Harris 1, S Meek 1
PMCID: PMC1726594  PMID: 16244331

Full Text

The Full Text of this article is available as a PDF (81.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agnelli Giancarlo, Becattini Cecilia, Kirschstein Timo. Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcome-based meta-analysis. Arch Intern Med. 2002 Dec 9;162(22):2537–2541. doi: 10.1001/archinte.162.22.2537. [DOI] [PubMed] [Google Scholar]
  2. Aklog Lishan, Williams Christopher S., Byrne John G., Goldhaber Samuel Z. Acute pulmonary embolectomy: a contemporary approach. Circulation. 2002 Mar 26;105(12):1416–1419. doi: 10.1161/01.cir.0000012526.21603.25. [DOI] [PubMed] [Google Scholar]
  3. Alpert J. S., Smith R., Carlson J., Ockene I. S., Dexter L., Dalen J. E. Mortality in patients treated for pulmonary embolism. JAMA. 1976 Sep 27;236(13):1477–1480. [PubMed] [Google Scholar]
  4. Arcasoy S. M., Kreit J. W. Thrombolytic therapy of pulmonary embolism: a comprehensive review of current evidence. Chest. 1999 Jun;115(6):1695–1707. doi: 10.1378/chest.115.6.1695. [DOI] [PubMed] [Google Scholar]
  5. BARRITT D. W., JORDAN S. C. Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet. 1960 Jun 18;1(7138):1309–1312. doi: 10.1016/s0140-6736(60)92299-6. [DOI] [PubMed] [Google Scholar]
  6. Bailén M. R., Cuadra J. A., Aguayo De Hoyos E. Thrombolysis during cardiopulmonary resuscitation in fulminant pulmonary embolism: a review. Crit Care Med. 2001 Nov;29(11):2211–2219. doi: 10.1097/00003246-200111000-00027. [DOI] [PubMed] [Google Scholar]
  7. British Thoracic Society Standards of Care Committee Pulmonary Embolism Guideline Development Group British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax. 2003 Jun;58(6):470–483. doi: 10.1136/thorax.58.6.470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Böttiger B. W., Bode C., Kern S., Gries A., Gust R., Glätzer R., Bauer H., Motsch J., Martin E. Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial. Lancet. 2001 May 19;357(9268):1583–1585. doi: 10.1016/S0140-6736(00)04726-7. [DOI] [PubMed] [Google Scholar]
  9. Carson J. L., Kelley M. A., Duff A., Weg J. G., Fulkerson W. J., Palevsky H. I., Schwartz J. S., Thompson B. T., Popovich J., Jr, Hobbins T. E. The clinical course of pulmonary embolism. N Engl J Med. 1992 May 7;326(19):1240–1245. doi: 10.1056/NEJM199205073261902. [DOI] [PubMed] [Google Scholar]
  10. Clarke D. B., Abrams L. D. Pulmonary embolectomy: a 25 year experience. J Thorac Cardiovasc Surg. 1986 Sep;92(3 Pt 1):442–445. [PubMed] [Google Scholar]
  11. Dalen J. E., Banas J. S., Jr, Brooks H. L., Evans G. L., Paraskos J. A., Dexter L. Resolution rate of acute pulmonary embolism in man. N Engl J Med. 1969 May 29;280(22):1194–1199. doi: 10.1056/NEJM196905292802202. [DOI] [PubMed] [Google Scholar]
  12. Dalla-Volta S., Palla A., Santolicandro A., Giuntini C., Pengo V., Visioli O., Zonzin P., Zanuttini D., Barbaresi F., Agnelli G. PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J Am Coll Cardiol. 1992 Sep;20(3):520–526. doi: 10.1016/0735-1097(92)90002-5. [DOI] [PubMed] [Google Scholar]
  13. De Gregorio Miguel Angel, Gimeno M. J., Mainar A., Herrera M., Tobio R., Alfonso R., Medrano J., Fava M. Mechanical and enzymatic thrombolysis for massive pulmonary embolism. J Vasc Interv Radiol. 2002 Feb;13(2 Pt 1):163–169. doi: 10.1016/s1051-0443(07)61933-2. [DOI] [PubMed] [Google Scholar]
  14. Doerge H., Schoendube F. A., Voss M., Seipelt R., Messmer B. J. Surgical therapy of fulminant pulmonary embolism: early and late results. Thorac Cardiovasc Surg. 1999 Feb;47(1):9–13. doi: 10.1055/s-2007-1013100. [DOI] [PubMed] [Google Scholar]
  15. Fava M., Loyola S., Flores P., Huete I. Mechanical fragmentation and pharmacologic thrombolysis in massive pulmonary embolism. J Vasc Interv Radiol. 1997 Mar-Apr;8(2):261–266. doi: 10.1016/s1051-0443(97)70552-9. [DOI] [PubMed] [Google Scholar]
  16. Fava M., Loyola S., Huete I. Massive pulmonary embolism: treatment with the hydrolyser thrombectomy catheter. J Vasc Interv Radiol. 2000 Oct;11(9):1159–1164. doi: 10.1016/s1051-0443(07)61357-8. [DOI] [PubMed] [Google Scholar]
  17. Goldhaber S. Z., Agnelli G., Levine M. N. Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism Group. Chest. 1994 Sep;106(3):718–724. doi: 10.1378/chest.106.3.718. [DOI] [PubMed] [Google Scholar]
  18. Goldhaber S. Z., Haire W. D., Feldstein M. L., Miller M., Toltzis R., Smith J. L., Taveira da Silva A. M., Come P. C., Lee R. T., Parker J. A. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet. 1993 Feb 27;341(8844):507–511. doi: 10.1016/0140-6736(93)90274-k. [DOI] [PubMed] [Google Scholar]
  19. Goldhaber S. Z., Haire W. D., Feldstein M. L., Miller M., Toltzis R., Smith J. L., Taveira da Silva A. M., Come P. C., Lee R. T., Parker J. A. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet. 1993 Feb 27;341(8844):507–511. doi: 10.1016/0140-6736(93)90274-k. [DOI] [PubMed] [Google Scholar]
  20. Goldhaber S. Z., Kessler C. M., Heit J. A., Elliott C. G., Friedenberg W. R., Heiselman D. E., Wilson D. B., Parker J. A., Bennett D., Feldstein M. L. Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial. J Am Coll Cardiol. 1992 Jul;20(1):24–30. doi: 10.1016/0735-1097(92)90132-7. [DOI] [PubMed] [Google Scholar]
  21. Goldhaber S. Z., Kessler C. M., Heit J., Markis J., Sharma G. V., Dawley D., Nagel J. S., Meyerovitz M., Kim D., Vaughan D. E. Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism. Lancet. 1988 Aug 6;2(8606):293–298. doi: 10.1016/s0140-6736(88)92354-9. [DOI] [PubMed] [Google Scholar]
  22. Goldhaber S. Z. Pulmonary embolism thrombolysis: broadening the paradigm for its administration. Circulation. 1997 Aug 5;96(3):716–718. doi: 10.1161/01.cir.96.3.716. [DOI] [PubMed] [Google Scholar]
  23. Goldhaber S. Z., Visani L., De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) Lancet. 1999 Apr 24;353(9162):1386–1389. doi: 10.1016/s0140-6736(98)07534-5. [DOI] [PubMed] [Google Scholar]
  24. Green S. M., Rothrock S. G. Intravenous magnesium for acute asthma: failure to decrease emergency treatment duration or need for hospitalization. Ann Emerg Med. 1992 Mar;21(3):260–265. doi: 10.1016/s0196-0644(05)80885-6. [DOI] [PubMed] [Google Scholar]
  25. Greenfield L. J. Catheter pulmonary embolectomy. Chest. 1991 Sep;100(3):593–594. doi: 10.1378/chest.100.3.593. [DOI] [PubMed] [Google Scholar]
  26. Gulba D. C., Bode C., Runge M. S., Huber K. Thrombolytic agents--an overview. Ann Hematol. 1996;73 (Suppl 1):S9–27. [PubMed] [Google Scholar]
  27. Gulba D. C., Schmid C., Borst H. G., Lichtlen P., Dietz R., Luft F. C. Medical compared with surgical treatment for massive pulmonary embolism. Lancet. 1994 Mar 5;343(8897):576–577. doi: 10.1016/s0140-6736(94)91523-7. [DOI] [PubMed] [Google Scholar]
  28. Hamel E., Pacouret G., Vincentelli D., Forissier J. F., Peycher P., Pottier J. M., Charbonnier B. Thrombolysis or heparin therapy in massive pulmonary embolism with right ventricular dilation: results from a 128-patient monocenter registry. Chest. 2001 Jul;120(1):120–125. doi: 10.1378/chest.120.1.120. [DOI] [PubMed] [Google Scholar]
  29. Hull R. D., Raskob G. E., Carter C. J., Coates G., Gill G. J., Sackett D. L., Hirsh J., Thompson M. Pulmonary embolism in outpatients with pleuritic chest pain. Arch Intern Med. 1988 Apr;148(4):838–844. [PubMed] [Google Scholar]
  30. Isoda K., Satomura K., Hamabe A., Hagisawa K., Kamezawa Y., Sugiyabu Y., Kurita A., Nakamura H. A case of acute massive pulmonary thromboembolism treated by mechanical clot fragmentation using a percutaneous transluminal angioplasty balloon. Jpn Circ J. 1997 Jun;61(6):531–535. doi: 10.1253/jcj.61.531. [DOI] [PubMed] [Google Scholar]
  31. Janata-Schwatczek K., Weiss K., Riezinger I., Bankier A., Domanovits H., Seidler D. Pulmonary embolism. II. Diagnosis and treatment. Semin Thromb Hemost. 1996;22(1):33–52. doi: 10.1055/s-2007-998990. [DOI] [PubMed] [Google Scholar]
  32. Jerjes-Sanchez C, Ramírez-Rivera A, de Lourdes García M, Arriaga-Nava R, Valencia S, Rosado-Buzzo A, Pierzo JA, Rosas E. Streptokinase and Heparin versus Heparin Alone in Massive Pulmonary Embolism: A Randomized Controlled Trial. J Thromb Thrombolysis. 1995;2(3):227–229. doi: 10.1007/BF01062714. [DOI] [PubMed] [Google Scholar]
  33. Kanter D. S., Mikkola K. M., Patel S. R., Parker J. A., Goldhaber S. Z. Thrombolytic therapy for pulmonary embolism. Frequency of intracranial hemorrhage and associated risk factors. Chest. 1997 May;111(5):1241–1245. doi: 10.1378/chest.111.5.1241. [DOI] [PubMed] [Google Scholar]
  34. Kasper W., Konstantinides S., Geibel A., Olschewski M., Heinrich F., Grosser K. D., Rauber K., Iversen S., Redecker M., Kienast J. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol. 1997 Nov 1;30(5):1165–1171. doi: 10.1016/s0735-1097(97)00319-7. [DOI] [PubMed] [Google Scholar]
  35. Kasper W., Konstantinides S., Geibel A., Tiede N., Krause T., Just H. Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism. Heart. 1997 Apr;77(4):346–349. doi: 10.1136/hrt.77.4.346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Koning R., Cribier A., Gerber L., Eltchaninoff H., Tron C., Gupta V., Soyer R., Letac B. A new treatment for severe pulmonary embolism: percutaneous rheolytic thrombectomy. Circulation. 1997 Oct 21;96(8):2498–2500. doi: 10.1161/01.cir.96.8.2498. [DOI] [PubMed] [Google Scholar]
  37. Konstantinides S., Geibel A., Olschewski M., Heinrich F., Grosser K., Rauber K., Iversen S., Redecker M., Kienast J., Just H. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry. Circulation. 1997 Aug 5;96(3):882–888. doi: 10.1161/01.cir.96.3.882. [DOI] [PubMed] [Google Scholar]
  38. Konstantinides Stavros, Geibel Annette, Heusel Gerhard, Heinrich Fritz, Kasper Wolfgang, Management Strategies and Prognosis of Pulmonary Embolism-3 Trial Investigators Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med. 2002 Oct 10;347(15):1143–1150. doi: 10.1056/NEJMoa021274. [DOI] [PubMed] [Google Scholar]
  39. Konstantinides Stavros, Geibel Annette, Heusel Gerhard, Heinrich Fritz, Kasper Wolfgang, Management Strategies and Prognosis of Pulmonary Embolism-3 Trial Investigators Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med. 2002 Oct 10;347(15):1143–1150. doi: 10.1056/NEJMoa021274. [DOI] [PubMed] [Google Scholar]
  40. Levine M., Hirsh J., Weitz J., Cruickshank M., Neemeh J., Turpie A. G., Gent M. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest. 1990 Dec;98(6):1473–1479. doi: 10.1378/chest.98.6.1473. [DOI] [PubMed] [Google Scholar]
  41. Ly B., Arnesen H., Eie H., Hol R. A controlled clinical trial of streptokinase and heparin in the treatment of major pulmonary embolism. Acta Med Scand. 1978;203(6):465–470. doi: 10.1111/j.0954-6820.1978.tb14909.x. [DOI] [PubMed] [Google Scholar]
  42. Marini C., Di Ricco G., Rossi G., Rindi M., Palla R., Giuntini C. Fibrinolytic effects of urokinase and heparin in acute pulmonary embolism: a randomized clinical trial. Respiration. 1988;54(3):162–173. doi: 10.1159/000195517. [DOI] [PubMed] [Google Scholar]
  43. Meneveau N., Schiele F., Metz D., Valette B., Attali P., Vuillemenot A., Grollier G., Elaerts J., Mossard J. M., Viel J. F. Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic outcome and one-year follow-up. J Am Coll Cardiol. 1998 Apr;31(5):1057–1063. doi: 10.1016/s0735-1097(98)00068-0. [DOI] [PubMed] [Google Scholar]
  44. Meneveau N., Schiele F., Vuillemenot A., Valette B., Grollier G., Bernard Y., Bassand J. P. Streptokinase vs alteplase in massive pulmonary embolism. A randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction. Eur Heart J. 1997 Jul;18(7):1141–1148. doi: 10.1093/oxfordjournals.eurheartj.a015410. [DOI] [PubMed] [Google Scholar]
  45. Meyer G., Brenot F., Pacouret G., Simonneau G., Gillet Juvin K., Charbonnier B., Sors H. Subcutaneous low-molecular-weight heparin fragmin versus intravenous unfractionated heparin in the treatment of acute non massive pulmonary embolism: an open randomized pilot study. Thromb Haemost. 1995 Dec;74(6):1432–1435. [PubMed] [Google Scholar]
  46. Meyer G., Sors H., Charbonnier B., Kasper W., Bassand J. P., Kerr I. H., Lesaffre E., Vanhove P., Verstraete M. Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicenter double-blind trial. The European Cooperative Study Group for Pulmonary Embolism. J Am Coll Cardiol. 1992 Feb;19(2):239–245. doi: 10.1016/0735-1097(92)90472-y. [DOI] [PubMed] [Google Scholar]
  47. Mikkola K. M., Patel S. R., Parker J. A., Grodstein F., Goldhaber S. Z. Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis. Am Heart J. 1997 Jul;134(1):69–72. doi: 10.1016/s0002-8703(97)70108-x. [DOI] [PubMed] [Google Scholar]
  48. Modan B., Sharon E., Jelin N. Factors contributing to the incorrect diagnosis of pulmonary embolic disease. Chest. 1972 Oct;62(4):388–393. doi: 10.1378/chest.62.4.388. [DOI] [PubMed] [Google Scholar]
  49. Müller-Hülsbeck S., Brossmann J., Jahnke T., Grimm J., Reuter M., Bewig B., Heller M. Mechanical thrombectomy of major and massive pulmonary embolism with use of the Amplatz thrombectomy device. Invest Radiol. 2001 Jun;36(6):317–322. doi: 10.1097/00004424-200106000-00003. [DOI] [PubMed] [Google Scholar]
  50. Newman D. H., Greenwald I., Callaway C. W. Cardiac arrest and the role of thrombolytic agents. Ann Emerg Med. 2000 May;35(5):472–480. [PubMed] [Google Scholar]
  51. Oger E. Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost. 2000 May;83(5):657–660. [PubMed] [Google Scholar]
  52. Pineda L. A., Hathwar V. S., Grant B. J. Clinical suspicion of fatal pulmonary embolism. Chest. 2001 Sep;120(3):791–795. doi: 10.1378/chest.120.3.791. [DOI] [PubMed] [Google Scholar]
  53. Robertson C., Steen P., Adgey J., Bossaert L., Carli P., Chamberlain D., Dick W., Ekstrom L., Hapnes S. A., Holmberg S. The 1998 European Resuscitation Council guidelines for adult advanced life support: A statement from the Working Group on Advanced Life Support, and approved by the executive committee. Resuscitation. 1998 May;37(2):81–90. doi: 10.1016/s0300-9572(98)00035-5. [DOI] [PubMed] [Google Scholar]
  54. Robin E. D., McCauley R. F. The diagnosis of pulmonary embolism. When will we ever learn? Chest. 1995 Jan;107(1):3–4. doi: 10.1378/chest.107.1.3. [DOI] [PubMed] [Google Scholar]
  55. Schmitz-Rode T., Janssens U., Schild H. H., Basche S., Hanrath P., Günther R. W. Fragmentation of massive pulmonary embolism using a pigtail rotation catheter. Chest. 1998 Nov;114(5):1427–1436. doi: 10.1378/chest.114.5.1427. [DOI] [PubMed] [Google Scholar]
  56. Simonneau G., Sors H., Charbonnier B., Page Y., Laaban J. P., Azarian R., Laurent M., Hirsch J. L., Ferrari E., Bosson J. L. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire. N Engl J Med. 1997 Sep 4;337(10):663–669. doi: 10.1056/NEJM199709043371002. [DOI] [PubMed] [Google Scholar]
  57. Sors H., Pacouret G., Azarian R., Meyer G., Charbonnier B., Simonneau G. Hemodynamic effects of bolus vs 2-h infusion of alteplase in acute massive pulmonary embolism. A randomized controlled multicenter trial. Chest. 1994 Sep;106(3):712–717. doi: 10.1378/chest.106.3.712. [DOI] [PubMed] [Google Scholar]
  58. Stock K. W., Jacob A. L., Schnabel K. J., Bongartz G., Steinbrich W. Massive pulmonary embolism: treatment with thrombus fragmentation and local fibrinolysis with recombinant human-tissue plasminogen activator. Cardiovasc Intervent Radiol. 1997 Sep-Oct;20(5):364–368. doi: 10.1007/s002709900169. [DOI] [PubMed] [Google Scholar]
  59. Tebbe U., Graf A., Kamke W., Zahn R., Forycki F., Kratzsch G., Berg G. Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism. Am Heart J. 1999 Jul;138(1 Pt 1):39–44. doi: 10.1016/s0002-8703(99)70243-7. [DOI] [PubMed] [Google Scholar]
  60. Thabut Gabriel, Thabut Dominique, Myers Robert P., Bernard-Chabert Brigitte, Marrash-Chahla Rolana, Mal Hervé, Fournier Michel. Thrombolytic therapy of pulmonary embolism: a meta-analysis. J Am Coll Cardiol. 2002 Nov 6;40(9):1660–1667. doi: 10.1016/s0735-1097(02)02381-1. [DOI] [PubMed] [Google Scholar]
  61. Tibbutt D. A., Davies J. A., Anderson J. A., Fletcher E. W., Hamill J., Holt J. M., Thomas M. L., Lee G., Miller G. A., Sharp A. A. Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonay embolism. Br Med J. 1974 Mar 2;1(5904):343–347. doi: 10.1136/bmj.1.5904.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Verstraete M., Miller G. A., Bounameaux H., Charbonnier B., Colle J. P., Lecorf G., Marbet G. A., Mombaerts P., Olsson C. G. Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism. Circulation. 1988 Feb;77(2):353–360. doi: 10.1161/01.cir.77.2.353. [DOI] [PubMed] [Google Scholar]

Articles from Emergency Medicine Journal : EMJ are provided here courtesy of BMJ Publishing Group

RESOURCES